数据链接：
官方服务：
资源简介：
Factors associated with SVR12 achievement.
应用场景：
创建时间：
2020-02-13
相关数据集
Mechanisms of Restoring T Cell Immunity after Cure of Chronic Viral Infection
We analyzed hepatitis C virus (HCV)-specific T cells and non-specific memory T cell populations from 6 patients with chronic HCV infection receiving 12 weeks of direct-acting antiviral (DAA) therapy w
NIAID Data Ecosystem80
sj-7z-4-tan-10.1177_17562864221080520 – for Factors affecting minimal manifestation status induction in myasthenia gravis
sj-7z-4-tan-10.1177_17562864221080520 for Factors affecting minimal manifestation status induction in myasthenia gravis by Yi Li, Shumei Yang, Xiaohua Dong, Zhibin Li, Yuyao Peng, Wanlin Jin, Di Chen,
DataCite Commons2024-08-28 更新70
Reasons for discontinuation of telaprevir and incidence of the most common AEs and Grade 3–4 AEs during the telaprevir phase in the intent-to-treat population.
* Includes six F0–F2 patients.† Listed are drug-related AEs that occurred in at least 5% of the overall population during the telaprevir phase.‡ Included in this category are all related events that w
Figshare2015-12-03 更新40
Supplementary Material for: Serum angiopoietin-2 levels predict the development of hepatocellular carcinoma following hepatitis C virus eradication using direct-acting antiviral agents
Introduction: Our previous studies showed that serum angiopoietin-2 (Ang-2) and C-X-C motif chemokine ligand 10 (CXCL10) levels predicted improvement in liver fibrosis following sustained virological
DataCite Commons2024-07-25 更新80
Data related to treatment optimisation for hepatitis C in the era of combination direct-acting antiviral therapy: systematic review and meta-analysis
This data archive contains the following 7 files relating to treatment optimisation for hepatitis C in the era of combination direct-acting antiviral therapy: - Supplementary figure 1: Thematic map
NIAID Data Ecosystem50
